{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:29:44Z","timestamp":1777984184142,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ajog.2019.11.1264","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T07:13:25Z","timestamp":1575270805000},"page":"499.e1-499.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["First-trimester maternal serum alpha fetoprotein is associated with ischemic placental disease"],"prefix":"10.1016","volume":"222","author":[{"given":"Cheryl","family":"Dinglas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nur","family":"Afsar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8475-3357","authenticated-orcid":false,"given":"Elizabeth","family":"Cochrane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meredith","family":"Akerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Wells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Chavez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye","family":"Heo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Vintzileos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2019.11.1264_bib1","first-page":"1","article-title":"First trimester ultrasound tests alone or in combination with first trimester serum tests for Down syndrome screening","volume":"3","author":"Alldred","year":"2017","journal-title":"Cochrane Database Sys Rev"},{"key":"10.1016\/j.ajog.2019.11.1264_bib2","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/0002-9378(84)90530-1","article-title":"An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities","volume":"148","author":"Merkatz","year":"1984","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.11.1264_bib3","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.ajog.2004.06.052","article-title":"First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial)","volume":"191","author":"Dugoff","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.11.1264_bib4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/uog.5163","article-title":"First trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery","volume":"31","author":"Spencer","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.11.1264_bib5","doi-asserted-by":"crossref","first-page":"514.e1","DOI":"10.1016\/j.ajog.2014.04.018","article-title":"Prediction of preeclampsia utilizing the first trimester screening examination","volume":"211","author":"Baschat","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.11.1264_bib6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/AOG.0000000000001889","article-title":"First-trimester and second-trimester maternal serum biomarkers as predictors of placental abruption","volume":"129","author":"Ananth","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.11.1264_bib7","first-page":"006","article-title":"Utility of maternal serum analyte screening in the era of cell-free fetal DNA","volume":"1","author":"Herrera","year":"2017","journal-title":"J\u00a0Gynecol Obstet"},{"key":"10.1016\/j.ajog.2019.11.1264_bib8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1055\/s-2006-947724","article-title":"Evaluating the thresholds of abnormal second trimester multiple marker screening tests associated with intra-uterine growth restriction","volume":"23","author":"Odibo","year":"2006","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2019.11.1264_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.AOG.0000191302.79560.d8","article-title":"Pregnancy-associated plasma protein-A and alpha-fetoprotein and prediction of adverse perinatal outcome","volume":"107","author":"Smith","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.11.1264_bib10","first-page":"267","article-title":"Maternal serum analytes as markers of adverse obstetric outcomes","volume":"14","author":"Lakhi","year":"2012","journal-title":"Obtetric Gyneacol"},{"key":"10.1016\/j.ajog.2019.11.1264_bib11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejogrb.2014.07.018","article-title":"Predictive value of combined serum biomarkers for adverse pregnancy outcomes","volume":"181","author":"Cohen","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2019.11.1264_bib12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000336662","article-title":"Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis","volume":"31","author":"Roberge","year":"2012","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajog.2019.11.1264_bib13","doi-asserted-by":"crossref","first-page":"268.e1","DOI":"10.1016\/j.ajog.2008.06.071","article-title":"Serum inhibin A and angiogenic factor levels in pregnancies with previous preeclampsia and\/or chronic hypertension: are they useful markers for prediction of subsequent preeclampsia?","volume":"199","author":"Sibai","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.11.1264_bib14","first-page":"22","article-title":"Improved early prediction of preterm preeclampsia by combining second trimester maternal serum alpha-fetoprotein and uterine artery Doppler","volume":"3","author":"Allen","year":"2014","journal-title":"J\u00a0Clin Gynecol Obstet"},{"key":"10.1016\/j.ajog.2019.11.1264_bib15","first-page":"17","article-title":"Pregnancy outcomes after increasing maternal serum alpha fetoprotein levels","volume":"74","author":"Robinson","year":"1989","journal-title":"Obtet Gynecol"},{"key":"10.1016\/j.ajog.2019.11.1264_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.semperi.2014.03.001","article-title":"Ischemic placental disease: a unifying concept for preeclampsia, intrauterine growth restriction, and placental abruption","volume":"38","author":"Ananth","year":"2014","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.ajog.2019.11.1264_bib17","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/pd.4597","article-title":"First trimester screening for Down syndrome using nuchal translucency, maternal serum pregnancy-associated plasma protein A, free-B human chorionic gonadotropin, placental growth factor, and alpha-fetoprotein","volume":"35","author":"Huang","year":"2015","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2019.11.1264_bib18","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/pd.5090","article-title":"Expanded conventional first trimester screening","volume":"37","author":"Carmichael","year":"2017","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2019.11.1264_bib19","doi-asserted-by":"crossref","first-page":"126.e1","DOI":"10.1016\/j.ajog.2017.10.024","article-title":"First trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and placental volume","volume":"218","author":"Sonek","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.11.1264_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.placenta.2019.04.005","article-title":"The association between first trimester AFP to PAPP-A ratio and placentally related adverse pregnancy outcome","volume":"81","author":"Hughes","year":"2019","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2019.11.1264_bib21","doi-asserted-by":"crossref","first-page":"f6564","DOI":"10.1136\/bmj.f6564","article-title":"Pre-eclampsia rates in the United States, 1980\u20132010: age-period-cohort analysis","volume":"347","author":"Ananth","year":"2013","journal-title":"Br Med J"},{"key":"10.1016\/j.ajog.2019.11.1264_bib22","doi-asserted-by":"crossref","first-page":"199.e1","DOI":"10.1016\/j.ajog.2018.11.1087","article-title":"Predictive performance of the competing risk model in screening for preeclampsia","volume":"220","author":"Wright","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.11.1264_bib23","doi-asserted-by":"crossref","first-page":"197.e1","DOI":"10.1016\/j.ajog.2018.10.092","article-title":"Two-stage screening for preterm preeclampsia at 11\u201313 weeks' gestation","volume":"220","author":"Wright","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.11.1264_bib24","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ajog.2018.05.042","article-title":"Application of a preeclampsia screening algorithm in a low-risk nulliparous population","volume":"219","author":"Mone","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.11.1264_bib25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/j.semperi.2014.03.005","article-title":"Pathophysiology of ischemic placental disease","volume":"38","author":"Roberts","year":"2014","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.ajog.2019.11.1264_bib26","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/aogs.12194","article-title":"Placental abruption and placental weight\u2014implications for fetal growth","volume":"92","author":"Ananth","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2019.11.1264_bib27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/j.semperi.2014.03.004","article-title":"Epidemiology of ischemic placental disease: a focus on preterm gestations","volume":"38","author":"Parker","year":"2014","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.ajog.2019.11.1264_bib28","first-page":"2033","article-title":"Ischemic placental syndrome\u2014prediction and new disease monitoring","volume":"29","author":"Kwiatkowski","year":"2016","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2019.11.1264_bib29","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.ajog.2006.05.021","article-title":"Maternal-fetal conditions necessitating a medical intervention resulting in preterm birth","volume":"195","author":"Ananth","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.11.1264_bib30","doi-asserted-by":"crossref","first-page":"399.e1","DOI":"10.1016\/j.ajog.2018.06.011","article-title":"Low-dose aspirin is associated with reduced spontaneous preterm birth in nulliparous women","volume":"219","author":"Andrikopoulou","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.11.1264_bib31","doi-asserted-by":"crossref","first-page":"255.e1","DOI":"10.1016\/j.ajog.2019.04.027","article-title":"A\u00a0pharmacokinetic assessment of optimal dosing, preparation and chronotherapy of aspirin in pregnancy","volume":"221","author":"Shanmugalingam","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.11.1264_bib32","doi-asserted-by":"crossref","first-page":"580.e1","DOI":"10.1016\/j.ajog.2019.02.034","article-title":"Aspirin delays the development of preeclampsia","volume":"220","author":"Wright","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.11.1264_bib33","doi-asserted-by":"crossref","first-page":"385.e1","DOI":"10.1016\/j.ajog.2019.01.222","article-title":"Obesity and laboratory aspirin resistance in high-risk pregnant women treated with low-dose aspirin","volume":"220","author":"Finneran","year":"2019","journal-title":"Am J Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937819326857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937819326857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:27:51Z","timestamp":1757590071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937819326857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0002937819326857"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2019.11.1264","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First-trimester maternal serum alpha fetoprotein is associated with ischemic placental disease","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2019.11.1264","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}